Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Management of Hyponatremia

Initial Assessment and Classification

  • The American College of Neurosurgery recommends that hyponatremia is defined as serum sodium <135 mmol/L and should be further investigated when levels are <131 mmol/L 2, 1
  • Initial workup should include serum and urine osmolarity, urine electrolytes, uric acid, and assessment of extracellular fluid volume status to determine the underlying cause 1
  • Patients should be classified according to volume status: hypovolemic, euvolemic, or hypervolemic hyponatremia 1, 2

Treatment Based on Symptom Severity

  • For severe symptomatic hyponatremia, the American College of Neurosurgery recommends administering 3% hypertonic saline with an initial goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve 1, 2
  • The correction rate should not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome, as recommended by the American College of Neurosurgery 1, 2
  • The American College of Neurosurgery suggests considering ICU admission for close monitoring during treatment 1
  • Serum sodium should be monitored every 2 hours during initial correction, as recommended by the American College of Neurosurgery 1

Treatment Based on Volume Status

  • For euvolemic hyponatremia, fluid restriction to 1L/day is the cornerstone of treatment for mild/asymptomatic cases, as recommended by the American College of Neurosurgery 1, 2
  • The American College of Neurosurgery suggests considering pharmacological options for resistant cases, including urea, diuretics, lithium, and demeclocycline 1, 2
  • For hypervolemic hyponatremia, fluid restriction to 1000-1500 mL/day for moderate hyponatremia (Na <125 mmol/L) is recommended by the American College of Neurosurgery 1

Special Considerations for Neurosurgical Patients

  • The American College of Neurosurgery recommends that cerebral salt wasting (CSW) should be treated with replacement of sodium and intravenous fluids, not fluid restriction 2, 1
  • Fludrocortisone may be considered in the treatment of hyponatremia in subarachnoid hemorrhage patients at risk of vasospasm, as suggested by the American College of Neurosurgery 2
  • Hydrocortisone may be used to prevent natriuresis in subarachnoid hemorrhage patients, as recommended by the American College of Neurosurgery 2

Monitoring and Prevention of Complications

  • The American College of Neurosurgery recommends calculating sodium deficit using formula: Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1
  • If overcorrection occurs, consider relowering with electrolyte-free water or desmopressin, as suggested by the American College of Neurosurgery 1
  • Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction, as recommended by the American College of Neurosurgery 1, 2

Common Pitfalls to Avoid

  • Overly rapid correction of chronic hyponatremia leading to osmotic demyelination syndrome, as warned by the American College of Neurosurgery 1, 2
  • Inadequate monitoring during active correction, as cautioned by the American College of Neurosurgery 1
  • Using fluid restriction in CSW, which can worsen outcomes, as warned by the American College of Neurosurgery 2, 1
  • Failing to recognize and treat the underlying cause, as emphasized by the American College of Neurosurgery 1
  • Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms, as cautioned by the American College of Neurosurgery 1

REFERENCES

2

Management of Sodium Imbalance [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025